Cecilia Rorsman
YOU?
Author Swipe
View article: Risk factors and incidence of new-onset heart failure with conventional pacemaker implant: A nationwide study
Risk factors and incidence of new-onset heart failure with conventional pacemaker implant: A nationwide study Open
Pacemaker therapy is associated with >20% risk of new-onset HF within 5 years, and we identified 9 risk factors associated with the diagnosis of new-onset HF. The proposed score based on these variables can be used to identify patients at …
View article: Age-Stratified Clinical Outcome in Patients with Known Heart Failure Who Receive Pacemaker, Resynchronization Therapy, or Defibrillator Implants
Age-Stratified Clinical Outcome in Patients with Known Heart Failure Who Receive Pacemaker, Resynchronization Therapy, or Defibrillator Implants Open
Introduction: Patients with heart failure (HF) and bradycardia may be eligible for different types of cardiac implantable electronic devices (CIED), depending on the presence of atrioventricular conduction disease, age, and comorbidities. …
View article: Early ICD implantation following out-of-hospital cardiac arrest: a retrospective cohort study from the Swedish Registry for Cardiopulmonary Resuscitation
Early ICD implantation following out-of-hospital cardiac arrest: a retrospective cohort study from the Swedish Registry for Cardiopulmonary Resuscitation Open
Background It is unclear whether an implantable cardioverter-defibrillator (ICD) is generally beneficial in survivors of out-of-hospital cardiac arrest (OHCA). Objective We studied the association between ICD implantation prior to discharg…
View article: Choice of cardiac implantable electronic device and age-stratified clinical outcome in patients with known heart failure prior to implant
Choice of cardiac implantable electronic device and age-stratified clinical outcome in patients with known heart failure prior to implant Open
Background Patients with heart failure (HF) and bradycardia may be eligible for different types of cardiac implantable devices, depending on presence of AV conduction disease, left ventricular ejection fraction, severity of heart failure s…
View article: Risk factors and prognostic implications for new-onset heart failure with ventricular pacing - a nationwide study
Risk factors and prognostic implications for new-onset heart failure with ventricular pacing - a nationwide study Open
Background Studies have shown that the incidence of new-onset heart failure (HF) is higher for patients receiving pacemaker therapy with traditional right ventricular pacing, compared to age matched controls. Conduction system pacing may o…
View article: Sex‐based differences in cardiac resynchronization therapy upgrade and outcome for patients with pacemaker and new‐onset heart failure
Sex‐based differences in cardiac resynchronization therapy upgrade and outcome for patients with pacemaker and new‐onset heart failure Open
Background Patients with chronic right ventricular (RV) pacing are at an increased risk of heart failure. Previous studies have indicated that cardiac resynchronization therapy (CRT) is underused in this setting, and that there may be sex‐…
View article: Age-stratified comparison of prognosis in cardiac resynchronization therapy with or without prophylactic defibrillator for nonischemic cardiomyopathy—a nationwide cohort study
Age-stratified comparison of prognosis in cardiac resynchronization therapy with or without prophylactic defibrillator for nonischemic cardiomyopathy—a nationwide cohort study Open
Aims Prior studies have suggested that the benefit from primary preventive defibrillator treatment for patients with nonischemic cardiomyopathyy, treated with cardiac resynchronization therapy, may be age-dependent. We aimed to compare age…
View article: Role of baseline 12‑lead ECG in predicting syncope caused by arrhythmia in patients investigated using an implantable loop recorder
Role of baseline 12‑lead ECG in predicting syncope caused by arrhythmia in patients investigated using an implantable loop recorder Open
A baseline 12‑lead ECG with bifascicular block was a strong predictor for syncope during follow-up, most often due to bradyarrhythmia caused by intermittent complete heart block. No other ECG findings were associated with the ILR outcome. …
View article: Stroke incidence and anticoagulation treatment in patients with pacemaker-detected silent atrial fibrillation
Stroke incidence and anticoagulation treatment in patients with pacemaker-detected silent atrial fibrillation Open
The stroke risk in our study population with an incident silent AF diagnosis may have been significantly decreased by the high proportion of anticoagulation treatment. This could imply that without this treatment the stroke risk might have…
View article: P3621Incidence of ischemic stroke in a pacemaker population
P3621Incidence of ischemic stroke in a pacemaker population Open
Background/Introduction: The pattern of use of non-vitamin K antagonist oral anticoagulants (NOAC) in the management of non-valvular atrial fibrillation (NVAF) and the rates of haemorrhage associated with their use under real-life conditio…
View article: Low rate of and rapid attention to inappropriate ICD shocks with remote device and rhythm monitoring: a qualitative study
Low rate of and rapid attention to inappropriate ICD shocks with remote device and rhythm monitoring: a qualitative study Open
Objectives Inappropriate shocks are unpleasant and painful. We hypothesise that remote monitoring and careful attention to known and incident atrial fibrillation (AF) can reduce inappropriate shocks to a very low level in clinical praxis. …
View article: Is one month treatment with dabigatran before cardioversion of atrial fibrillation sufficient to prevent thromboembolism?: Table 1
Is one month treatment with dabigatran before cardioversion of atrial fibrillation sufficient to prevent thromboembolism?: Table 1 Open
In this retrospective study from clinical material, we found a low incidence of TE when dabigatran was used as TE prophylaxis in association with elective cardioversion. These results indicate that dabigatran is a safe alternative strategy…